摘要
^(99)Tc^m-生长抑素类似物眼眶显像在甲状腺相关性眼病患者诊疗中发挥着重要作用,其不仅可用于判断患者眶周炎性活动度、早期诊断疾病、决定是否需要治疗以及选择治疗方案,同时也为该病评价疗效、判断预后和相关研究提供重要的客观依据。因此,^(99)Tc^m-生长抑素类似物眼眶显像在甲状腺相关性眼病中的应用有助于规范该病诊疗行为,有效提高诊疗水平和效率。
Orbital scintigraphy with ^99Tcm-somatostatin analogue plays an important role in the diagnosis and treatment of patients with thyroid associated ophthalmopathy（TAO）. It can be used to determine the orbital inflammatory activity, early diagnose the diseases, determine the need for treatment and select treatment options. At the same time, it also provides an important objective evidence for the evaluation of curative effect, prognosis prediction and related clinical research. Therefore, the application of orbital scintigraphy with ^99Tcm-somatostatin analogue in TAO not only helps to standardize the diagnosis and treatment of the disease and obtain the best curative effect and prognosis, but also can effectively improve the overall level and efficiency of clinical diagnosis and treatment.
出处
《眼科》
CAS
CSCD
北大核心
2016年第6期361-364,共4页
Ophthalmology in China
关键词
生长抑素类似物
眼眶显像
甲状腺相关性眼病
somatostatin analogues
orbital scintigraphy
thyroid associated ophthalmopathy
